Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2010
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100310683 Pharmaceutical compositions for treating depression and anxiety
12/09/2010US20100310682 Pharmaceutical compositions for treating anxiety
12/09/2010US20100310681 Modulation of KCNQ Potassium Channel Activity for Treatment of Psychiatric Disorders and the Symptoms Thereof
12/09/2010US20100310674 Novel composition for treating the side effects of anticancer treatments
12/09/2010US20100310655 Crystal modification A of 1-(2,6-difluorobenzyl)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof
12/09/2010US20100310653 Use of an extract made of leaves of ginkgo biloba
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310641 Therapeutic approaches for treating cmt and related disorders
12/09/2010US20100310634 Transdermal therapeutic system having urea components
12/09/2010US20100310609 Compositions and methods for treatment of neurodegenerative diseases
12/09/2010US20100310608 Sequestering subunit and related compositions and methods
12/09/2010US20100310580 Compositions and methods for treating pruritus
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310575 Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders
12/09/2010US20100310570 Mapc treatment of brain injuries and diseases
12/09/2010US20100310568 Ninjurin-1 modulation and uses thereof
12/09/2010US20100310547 Treatment of Inflammatory Diseases
12/09/2010US20100310543 Method of preventing and treating acute brain pathologies
12/09/2010US20100310538 Use of r(+)-alpha-lipoic acid for cryptogenic neuropathy
12/09/2010US20100310529 Extracellular matrix from pluripotent cells
12/09/2010US20100310528 Vector System for Site-Specific Integration
12/09/2010US20100310525 Wnt pathway stimulation in reprogramming somatic cells
12/09/2010US20100310523 Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene
12/09/2010US20100310513 Bifidobacterial species
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010US20100310473 Targeting Brain Cells Via Ophthalmic Delivery
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310462 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010US20100310460 Compositions and methods for chelation therapy
12/09/2010DE102009023549A1 Use of hops for making a tea infusion and as auxiliary aid in nervousness, anxiety state, depression or sleep disorder, where debitterized hops are used
12/09/2010CA2764159A1 Active metabolite of a thrombin receptor antagonist
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010CA2763495A1 New compositions for treating cmt and related disorders
12/09/2010CA2760825A1 Modulation of kcnq potassium channel activity for treatment of psychiatric disorders and the symptoms thereof
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258841A1 Methods for treating pain
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258721A1 Polyethylene glycolated lactoferrin complex and method of producing the same
12/08/2010EP2258701A1 2-morpholino-4-pyrimidone compound
12/08/2010EP2258700A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258407A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/08/2010EP2258398A1 Albumin-amyloid peptide conjugates and uses thereof
12/08/2010EP2258396A1 Transdermally absorbable preparation
12/08/2010EP2258379A1 Use of platelet rich plasma composition
12/08/2010EP2258377A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids
12/08/2010EP2258372A1 A2A antagonists for use in the treatment of motor disorders
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258359A2 Neurogenesis by muscarinic receptor modulation with sabcomelin
12/08/2010EP2258358A2 Neurogenesis with acetylcholinesterase inhibitor
12/08/2010EP2258357A2 Neurogenesis with acetylcholinesterase inhibitor
12/08/2010EP2258353A2 Dosage form containing oxycodone and naloxone
12/08/2010EP2258347A2 Tamper-resistant products for opioid delivery
12/08/2010EP2258207A1 Pasteurisation process for microbial cells and microbial oil
12/08/2010EP2257570A2 Splice variants of gdnf and uses thereof
12/08/2010EP2257553A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
12/08/2010EP2257549A1 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloal kanes
12/08/2010EP2257546A2 Functionally selective alpha2c adrenoreceptor agonists
12/08/2010EP2257545A1 Pyrrolidinyl derivatives and uses thereof
12/08/2010EP2257543A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
12/08/2010EP2257542A1 Gamma secretase modulators for the treatment of alzheimer ' s disease
12/08/2010EP2257541A1 Modulators for amyloid beta
12/08/2010EP2257535A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
12/08/2010EP2257531A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP2257526A1 Spiro(5.5)undecane derivatives
12/08/2010EP2257517A1 Salts of memantine and cox-inhibitors and their crystal form in the treatment of pain
12/08/2010EP2257302A2 Extracts of sclerocarya birrea
12/08/2010EP2257294A2 Treatment of herpes virus related diseases
12/08/2010EP2257290A1 Kit, composition, product or medicament for treating cognitive impairment
12/08/2010EP2257281A2 Combination comprising a cannabinoid receptor binding compound and an opioid
12/08/2010EP1996584B1 Tropane prodrugs with central nervous system activity
12/08/2010EP1884237B1 Amidino derivatives for use in the prevention or treatment of glaucoma
12/08/2010EP1858857B1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
12/08/2010EP1853254B1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
12/08/2010EP1781290B1 Anti-inflammatory agents
12/08/2010EP1771432B1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
12/08/2010EP1578409B1 Use of adenosine a2a receptor antagonists for treatment or prevention of extra-pyramidal syndrome
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1480674B1 Treatment of central nervous system damage
12/08/2010EP1471926B1 Compositions and methods for the therapeutic use of an atonal-associated sequence
12/08/2010EP1443958B1 Vaccine against infectious disease
12/08/2010EP1438329B1 Biologically active peptides and their use for repairing injured nerves
12/08/2010EP1383487B1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
12/08/2010EP1276878B1 Reversible immortalization
12/08/2010EP1270588B1 Novel collagen-like protein clac, precursor thereof and genes encoding the same
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN201664142U Moxa good-smelling pillow for cerebral-heart comfort
12/08/2010CN1977892B Method for regulating baicalin and baicalein ratio in scutellariae root extract
12/08/2010CN1895438B Chinese-medicinal composition for treating cephalagia and its preparation
12/08/2010CN1850271B Medicinal composition for treating neurasthenia or somatic form disorders
12/08/2010CN1821243B Substituted pyridine M1 receptor excitomotor, its preparing process and its use
1 ... 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 ... 1833